American College of Clinical Pharmacy
      Search      Cart
         

ACSAP 2022 Book 2 Infectious Diseases in Ambulatory Care


Member Price:
$80.00
Nonmember Price:
$120.00
ASHP members, please call (913)492-3311 to recieve member pricing. Your ASHP membership number and expiration date are required.

Ambulatory care clinical pharmacists are essential in preventing and treating a variety of infectious diseases. ACSAP 2022 Book 2 (Infectious Diseases in Ambulatory Care) presents evidence-based updates on the management of patients with these conditions and disorders. The target audience for the book is board-certified and advanced level ambulatory care clinical pharmacists who provide care for persons with or at risk of infectious diseases.

Daniel B. Chastain, Pharm.D., BCIDP
Chastain

The book contains four learning modules with a total available 16.0 continuing pharmacy education (CPE) credits. The content of Infectious Diseases in Ambulatory Care was developed under the leadership of Faculty Panel Chair Daniel B. Chastain, Pharm.D., BCIDP.

Chapters in the first module provide updates on the management of genitourinary infections and sexually transmitted infections. The second module focuses on treatment and prevention of HIV. The third module includes chapters on outpatient antimicrobial therapy and antimicrobial stewardship in ambulatory care. The fourth module is comprised of three interactive chapters on infectious diseases due to immunosuppressive therapies, pharmacokinetic and pharmacodynamic considerations in infectious diseases for ambulatory care clinical pharmacists, and acute bacterial skin and skin structure infections.

Each ACSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

  • Traditional review-style chapters
  • Interactive cases (a series of webpages, each introduced by a sample case-based question)
  • Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

ACSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice. Included with every purchase is an e-media version you can view on an e-reader, tablet, and iOS or Android smart phone.

Infectious Diseases in Ambulatory Care I 0217-9999-22-078-H01-P 3.5 CPE Hours
Infectious Diseases in Ambulatory Care II 0217-9999-22-079-H01-P 3.5 CPE Hours
Infectious Diseases in Ambulatory Care III 0217-9999-22-080-H01-P 3.5 CPE Hours
Infectious Diseases in Ambulatory Care IV 0217-9999-22-081-H01-P 5.5 CPE Hours
Release Date: July 15, 2022
BCACP Deadline: January 17, 2023
ACPE Deadline: July 15, 2025

ISBN: 978-1-952291-53-1
Publication Year: 2022
Format: PDF and ePub
Number of Pages: 200

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of of BCACP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Disclosures


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.